Funabashi, Japan

Kiyotomo Seto


Average Co-Inventor Count = 3.7

ph-index = 6

Forward Citations = 64(Granted Patents)


Location History:

  • Funabashi, JP (1986 - 1996)
  • Tokyo, JP (1999 - 2002)

Company Filing History:


Years Active: 1986-2002

Loading Chart...
14 patents (USPTO):Explore Patents

Title: Innovations by Kiyotomo Seto in Cardiac Medications

Introduction

Kiyotomo Seto is an accomplished inventor based in Funabashi, Japan, known for his significant contributions to the field of pharmaceuticals. With a total of 14 patents to his name, Seto has been at the forefront of innovative developments aimed at enhancing cardiac health.

Latest Patents

Among his latest innovations is a pioneering method for the optical resolution of piperidine carboxylic acid derivatives. This new method plays a crucial role in the development of medicines designed to combat cardiac insufficiency, showcasing Seto's dedication to improving patient outcomes in cardiovascular health.

Career Highlights

Seto's career is marked by his association with Nissan Chemical Industries Limited, where he applies his expertise in chemistry to foster advancements in medical treatments. His work has not only elevated the standard of medications available but has also contributed to broader research and development initiatives within the company.

Collaborations

Throughout his career, Seto has collaborated with esteemed colleagues such as Ryozo Sakoda and Hiroo Matsumoto. These partnerships have been instrumental in driving innovation and ensuring that cutting-edge research translates into effective therapies in the pharmaceutical industry.

Conclusion

Kiyotomo Seto's innovative spirit and commitment to advancing cardiac care through his inventions have established him as a prominent figure in the field. With a series of valuable patents and meaningful collaborations, Seto continues to influence the landscape of cardiac medication, benefitting patients and the healthcare community alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…